The company will upgrade its core technology for coordinating pharmaceutical development tasks through specialized AI agents.
The platform coordinates agents for protocol design, statistics and regulatory work. Its Protocol Rehearsal product simulates a proposed clinical trial before patient recruitment to explore enrollment rates, dropout risks and resource constraints.
The financing follows a separate $50 million Series D announced in December 2025. The company did not assign a series label to this new round. Index Capital advised on the transaction.
Waymo develops an autonomous-driving system and operates a commercial ride-hailing service with vehicles that carry passengers without a human driver.
World Labs develops AI world models that generate persistent 3D environments from text, images and video, with tools to edit and explore the resulting scenes.
Axiom Space develops commercial orbital infrastructure and spacesuits and provides private human spaceflight services.